# The Use of Intranasal Ketoralac for Pain Management (Sprix)

> **NCT01736358** · PHASE4 · TERMINATED · sponsor: **Montefiore Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Postoperative Pain Management
- Urolithiasis

## Interventions

- **DRUG:** Intranasal Ketoralac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01736358
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Interim analysis showed futility of primary endpoint
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736358, "The Use of Intranasal Ketoralac for Pain Management (Sprix)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01736358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*